(S1 (S (S (NP (NN Sanguinarine)) (VP (VBZ induces) (NP (NP (NN apoptosis)) (PP (IN of) (NP (JJ human) (NN osteosarcoma) (NNS cells)))) (PP (IN through) (NP (DT the) (ADJP (ADJP (JJ extrinsic)) (CC and) (ADJP (JJ intrinsic))) (NNS pathways))))) (. .)))
(S1 (S (S (S (NP (DT The) (JJ quaternary) (NN benzo-LSB-c-RSB-phenanthridine) (NN alkaloid) (NN sanguinarine)) (VP (VBZ inhibits) (NP (NP (DT the) (NN proliferation)) (PP (IN of) (NP (NP (JJ cancerous) (NNS cells)) (PP (IN from) (NP (NP (JJ different) (NNS origins)) (, ,) (PP (VBG including) (NP (NP (NN lung)) (, ,) (NP (NN breast)) (, ,) (NP (ADJP (JJ pancreatic))) (CC and) (NP (NN colon))))))))))) (, ,) (CC but) (S (NP (NN nothing)) (VP (VBZ is) (VP (VBN known) (PP (IN of) (NP (NP (PRP$ its) (NNS effects)) (PP (IN on) (NP (NP (NN osteosarcoma)) (, ,) (NP (DT a) (JJ primary) (JJ malignant) (NN bone) (NN tumour)))))))))) (. .)))
(S1 (S (S (NP (PRP We)) (VP (VBP have) (VP (VBN found) (SBAR (IN that) (S (NP (NN sanguinarine)) (VP (VP (VBZ alters) (NP (DT the) (NN morphology))) (CC and) (VP (VBZ reduces) (NP (NP (DT the) (NN viability)) (PP (IN of) (NP (NP (NN MG-63)) (CC and) (NP (NN SaOS-2) (JJ human) (NN osteosarcoma) (NN cell) (NNS lines)))) (PP (IN in) (NP (NP (NN concentration-)) (CC and) (NP (JJ time-dependent) (NN manner)))))))))))) (. .)))
(S1 (S (S (NP (NP (NN Incubation)) (PP (IN with) (NP (ADJP (CD 1) (NN micromol/L)) (NN sanguinarine))) (PP (IN for) (NP (NP (CD 4)) (CC and) (NP (CD 24h))))) (VP (VBD killed) (ADVP (RBR more) (RB efficiently)) (NP (NN MG-63) (NNS cells)) (PP (IN than) (NP (NN SaOS-2) (NNS cells))) (, ,) (SBAR (IN while) (S (NP (NP (NN incubation)) (PP (IN with) (NP (ADJP (CD 5) (NN micromol/L)) (NN sanguinarine)))) (VP (VBD killed) (NP (NP (QP (RB almost) (CD 100)) (NN %)) (PP (IN of) (NP (DT both) (NN cell) (NNS populations)))) (PP (IN within) (NP (NN 24h)))))))) (. .)))
(S1 (S (S (NP (DT This) (NN treatment)) (ADVP (RB also)) (VP (VBD changed) (NP (NP (DT the) (JJ mitochondrial) (NN membrane) (NN potential)) (PP (IN in) (NP (DT both) (NN MG-63) (CC and) (NN SaOS-2) (NNS cells)))) (PP (IN within) (NP (NP (NN 1h)) (, ,) (NP (VBN caused) (NN chromatin) (NN condensation)) (CC and) (NP (NP (DT the) (NN formation)) (PP (IN of) (NP (JJ apoptotic) (NNS bodies)))))))) (. .)))
(S1 (S (S (NP (PRP It)) (VP (VP (VBD activated) (NP (NN multicaspases))) (, ,) (CC and) (VP (VBD increased) (NP (NP (DT the) (NNS activities)) (PP (IN of) (NP (NP (NN caspase-8)) (CC and) (NP (NN caspase-9)))) (PP (IN in) (NP (DT both) (NN MG-63) (CC and) (NN SaOS-2) (NNS cells))))))) (. .)))
(S1 (S (S (NP (DT These) (NNS data)) (VP (VBP highlight) (NP (NN sanguinarine)) (PP (IN as) (NP (NP (DT a) (JJ novel) (JJ potential) (NN agent)) (PP (IN for) (NP (NN bone) (NN cancer) (NN therapy))))))) (. .)))
